Prediction of post-PCV13 pneumococcal evolution using invasive disease data enhanced by inverse-invasiveness weighting.
Qiu X, McGee L, Hammitt L, Grant LR, O'Brien KL, Hanage WP, Lipsitch M.
mBio. 2024 Aug 29. e0335523. PMID: 39207103
Other Positions
Faculty Affiliate in the Department of Immunology and Infectious Diseases
Immunology and Infectious Diseases
Harvard T.H. Chan School of Public Health
Director, Center for Communicable Disease Dynamics
Epidemiology
Harvard T.H. Chan School of Public Health
Links
Overview
I am Professor of Epidemiology with primary appointment in the Department of Epidemiology and an affiliated appointment in the Department of Immunology and Infectious Diseases, where my wet lab is located. I direct the Center for Communicable Disease Dynamics, a center of excellence funded by the MIDAS program of NIH/NIGMS. I am also the Associate Director of the Interdisciplinary Concentration in Infectious Disease Epidemiology.
B.A., 1991, Philosophy
Yale University
D.Phil, 1995, Zoology
University of Oxford
Bibliography
Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007-22).
Pham TM, Zhang Y, Nevers M, Li H, Khader K, Grad YH, Lipsitch M, Samore M.
Lancet Infect Dis. 2024 Aug 13. PMID: 39151443
Infectious disease surveillance needs for the United States: lessons from Covid-19.
Lipsitch M, Bassett MT, Brownstein JS, Elliott P, Eyre D, Grabowski MK, Hay JA, Johansson MA, Kissler SM, Larremore DB, Layden JE, Lessler J, Lynfield R, MacCannell D, Madoff LC, Metcalf CJE, Meyers LA, Ofori SK, Quinn C, Bento AI, Reich NG, Riley S, Rosenfeld R, Samore MH, Sampath R, Slayton RB, Swerdlow DL, Truelove S, Varma JK, Grad YH.
Front Public Health. 2024. 12:1408193. PMID: 39076420
Considerations for viral co-infection studies in human populations.
Chin T, Foxman EF, Watkins TA, Lipsitch M.
mBio. 2024 Jul 17. 15(7):e0065824. PMID: 38847531
Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection.
Bi Q, Dickerman BA, Nguyen HQ, Martin ET, Gaglani M, Wernli KJ, Balasubramani GK, Flannery B, Lipsitch M, Cobey S.
J Infect Dis. 2024 Apr 30. PMID: 38687898
Diagnostics for Public Health - Infectious Disease Surveillance and Control.
Lipsitch M, Grad Y.
NEJM Evid. 2024 May. 3(5):EVIDra2300271. PMID: 38815175
Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage.
Lewnard JA, Mahale P, Malden D, Hong V, Ackerson BK, Lewin BJ, Link-Gelles R, Feldstein LR, Lipsitch M, Tartof SY.
medRxiv. 2024 Apr 19. PMID: 38699313
Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection.
Bi Q, Dickerman BA, Nguyen HQ, Martin ET, Gaglani M, Wernli KJ, Balasubramani GK, Flannery B, Lipsitch M, Cobey S.
medRxiv. 2024 Apr 10. PMID: 37016669
Public role in research oversight.
Lipsitch M, Inglesby TV, Cicero A, Relman DA.
J Virol. 2024 Apr 16. 98(4):e0006124. PMID: 38477584
Optimal environmental testing frequency for outbreak surveillance.
Olejarz JW, Roster KIO, Kissler SM, Lipsitch M, Grad YH.
Epidemics. 2024 Mar. 46:100750. PMID: 38394927
News
Opinion: New policy would boost oversight of risky research
A federal policy set to go into effect in May 2025 would go a long way toward improving oversight of risky virus research, according to a New York Times opinion piece co-authored by Harvard Chan School's Marc Lipsitch.
Report calls for regulations around dangerous pathogen research
Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics at Harvard Chan School, discusses key takeaways from a new report that makes recommendations on strategies for conducting research on dangerous pathogens.
‘Emergency’ may be over but COVID still a threat, experts say
In the wake of the World Health Organization’s declaration on May 5 that it was ending the COVID global health emergency, experts acknowledged that the disease now poses much less of threat than it has over the past…
Alberto Ascherio, Marc Lipsitch among STAT’s picks for top leaders in life sciences
Harvard Chan School’s Alberto Ascherio and Marc Lipsitch are among 46 individuals in life sciences named to the 2023 STATUS List—a group of leaders in public health, medicine, biotechnology, and more, recognized by STAT for their contributions to…
The latest on the coronavirus
Harvard Chan School experts offer comments and context about the coronavirus in a variety of media outlets.
